Within PARC, one core element is participation and collaboration with relevant stakeholders. We therefore strive to include stakeholders from NGOs, academia, industry/ business associations, employer and worker representative bodies and patient organizations to foster collaboration and create synergies among our different stakeholders’ activities within PARC. An open call published last...

The Strategic Research and Innovation Agenda (SRIA) of the Partnership for the Assessment of Risks from Chemicals (PARC) is a document that outlines the main objectives, challenges and expected impacts of the partnership. It also defines the details of the research priorities and activities that will be implemented by PARC...

Within HBM4EU, we have created an approach to perform aligned pan-European occupational biomonitoring studies by multi-national collaboration. These kinds of studies can provide relevant and useful information to support EU-wide policy actions aiming to reduce occupational exposure to chemicals. The HBM4EU chromate study is an excellent example of the policy-relevant...

In such a large-scale partnership, establishing priorities is crucial to advance the knowledge and reach the objectives defined within its lifetime. PARC benefited from the HBM4EU legacy and, within work package (WP) 2 “A common science-policy-agenda”, Task 2.1 “Priority Setting” traced back the identification of the first set of priorities...